Astoria Portfolio Advisors
Astoria Portfolio Advisors Disclosure: At the time of these podcasts, Astoria held positions in COPX, PICK, XME, FBT, XBI, ARKG, XLE, KBWB, XLB, XLI, ICLN, EES, SPSM, IHDG, SPDW, CQQQ, MCHI, DGRE, VTIP, VOT, and EMB on behalf of its clients. There are no warranties implied. Astoria Portfolio Advisors LLC is a registered investment adviser located in New York. Astoria Portfolio Advisors LLC may only transact business in those states in which it is registered or qualifies for an exemption or exclusion from registration requirements. For full disclosure, please refer to our website: https://www.astoriaadvisors.com/disclaimer
For investors, ARKG’s active management and utility are vital because the fund is flexible and able to capitalize on genomics advancements more rapidly than index-based rivals. Those advancements include gene editing.
“Crispr-Cas9 is the second generation of technologies that seek to repair thousands of inherited genetic disorders and battle cancer in new ways. Gene editing is advancing so quickly that next-generation technologies are already on the heels of Crispr-Cas9, including a more-precise tool called base editing,” reports Bill Alpert for
Barron’s.
The CRISPR technology may also be under the spotlight as another disease fighting tool, with the world refocusing on the need for improved healthcare solutions.
January 19, 2021
Whether an ETF investor is looking for a short-term play or a buy-and-hold fund, ETFs with momentum can be an investor’s best friend. Here are three ETFs from provider DWS that are seeing strong momentum now, which could carry them through the remainder of 2021.
Broad Emerging Markets Exposure
ETF investors looking for broad emerging markets exposure can opt for the
Xtrackers MSCI Emerging Markets ESG Leaders Equity ETF (EMSG). EMSG seeks investment results that correspond generally to the performance, before fees and expenses, of the MSCI Emerging Markets ESG Leaders Index (the “underlying index”).
The fund will invest at least 80% of its total assets (but typically far more) in component securities (including depositary receipts in respect of such securities) of the underlying index. Using its 3-month chart and a stochastic relative strength index (StochRSI), while the fund is up over 200% from its 50-day moving average, the StochRSI is close to overs